Group One Trading’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Group One Trading's SMMT Position: Q3 2026 in Review
Group One Trading increased its Summit Therapeutics (SMMT) stake by 1.7% in Q3 2026, buying an estimated $11.6K and bringing the position to 45,223 shares worth $765K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.
Group One Trading first reported a position in SMMT in Q4 2018 and has held it in 21 quarters since. The position peaked at $4.09M in Q3 2024. 295 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Group One Trading held 45,223 shares of Summit Therapeutics worth $765K as of Q3 2026.
- Group One Trading bought 773 Summit Therapeutics shares in Q3 2026, an estimated $11.6K.
- Summit Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #3031 holding.
- Group One Trading first reported a position in Summit Therapeutics in Q4 2018 and has held it in 21 quarters since.
- Group One Trading's Summit Therapeutics position peaked at $4.09M in Q3 2024.
- 295 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.